1. Withaferin A inhibits apoptosis via activated Akt-mediated inhibition of oxidative stress.
- Author
-
Yan, Zheyi, Guo, Rui, Gan, Lu, Lau, Wayne Bond, Cao, Xiaoming, Zhao, Jianli, Ma, Xinliang, Christopher, Theodore A., Lopez, Bernard L., and Wang, Yajing
- Subjects
- *
WITHANIA somnifera , *APOPTOSIS , *CORONARY heart disease treatment , *PROTEIN kinase B , *OXIDATIVE stress , *HYDROGEN peroxide , *THERAPEUTICS - Abstract
Abstract Withaferin A (WFA), a withanolide derived from medicinal plant Withania somnifera , possesses anti-tumorigenic and immunomodulatory activities against various cancer cells. However, the role of WFA in myocardial ischemia reperfusion (MI/R) injury remains unclear. In the present study, we determined whether WFA may regulate cardiac ischemia reperfusion injury and elucidate the underlying mechanisms. We demonstrated that WFA enhanced H9c2 cells survival ability against simulated ischemia/reperfusion (SI/R) or hydrogen peroxide (H 2 O 2)-induced cell apoptosis. In addition, the enhanced oxidative stress induced by SI/R was inhibited by WFA. Among the multiple antioxidant molecules determined, antioxidants SOD2, SOD3, Prdx-1 was obviously upregulated by WFA. When Akt inhibitor IV was administrated, WFA's suppression effect on oxidative stress was obviously abolished. Additional experiments demonstrated that WFA successfully inhibited H 2 O 2 induced upregulation of SOD2, SOD3, and Prdx-1, ameliorated cardiomyocyte caspase-3 activity via an Akt dependent manner. Collectively, these results support the therapeutic potential of WFA against cardiac ischemia reperfusion injury and highlight the application of WFA in cardiovascular diseases holding great promise for the future. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF